What caused the jump in JNJ.SW stock today?

The jump to CHF188.82 was driven mainly by extremely low SIX volume (50 shares), which magnified price movement. There was no matching company earnings release in public feeds; technical illiquidity and cross‑listing mechanics likely produced the one‑day gap.

How does JNJ.SW stock compare to healthcare peers on valuation?

JNJ.SW's trailing PE of 26.35 is below the healthcare sector average PE of 33.43. However, its price/book of 7.30 is elevated versus book value. That mix suggests earnings strength but a premium on balance sheet metrics.

What targets does Meyka AI model for JNJ.SW stock?

Meyka AI's model gives a 12‑month base target of CHF210.00 (+11.22%) and a bullish target of CHF235.00 (+24.46%) from the current CHF188.82. Forecasts are projections and not guarantees.

Should traders act on the SIX move in JNJ.SW stock now?

Caution is advised. The SIX move looks liquidity-driven. Traders should seek confirming volume on major venues or a US-listed JNJ price change, and consider order size limits until a clear trend emerges.

CH Stocks

JNJ.SW jumps 39% to CHF188.82 at close: top gainer on SIX with analyst focus

ByHuzaifa Zahoor February 13, 2026February 13, 2026

JNJ.SW stock closed at CHF188.82 on 12 Feb 2026, up 39.45% from the prior close as the Swiss SIX listing finished the session as a top gainer. The move followed extremely low trading volume — 50 shares — which amplified price swings on the exchange. We review why the jump happened, link the price action to liquidity and valuation, and outline model-based targets and risk markers for investors.